32 research outputs found

    Hepatosplenic gamma-delta T-cell lymphoma in a female patient after delivery

    Get PDF
    Hepatosplenic γδ T-cell lymphoma (HSTCL) is a very rare peripheral T-cell lymphoma characterized by extranodal infiltration of mature malignant post-thymic T-lymphocytes into sinusoids of the liver and spleen without lymphadenopathy and significant cytopenias. The aetiology of the disease is unknown. We describe the case of a female patient in whom HSTCL developed after delivery and who was previously without disease. Flow cytometry and liver puncture are essential for diagnosing HSTCL, especially in patients with unexplained pancytopenia and hepatosplenomegaly. Since phenotypic results can easily be misinterpreted as non-malignant, the examiner should have enough experience to recognize clonal changes of T-lymphocytes. Namely, in contrast to B-lymphocytes, T-lymphocytes do not have an efficient indicator of clonality and are recognized by flow cytometry based only on aberrant expression of commonly present antigens of T-cell and NK-cell subsets. At present, there is no known cure for HSTCL with a maximum survival up to 2 years

    Prikaz bolnika z zasevkom v telesu vretenca L1 nejasnega izvora

    Get PDF
    Metastases of bone malignancies are much more common than primary neoplasms. The site of origin remains unknown in approximately 2% of metastases. We present a case of a 59-year-old patient referred to our Institute for pathological fracture of the L1 vertebral body. After removing the majority of the body, a detailed pathological examination and extensive diagnosis, the question of primary tumour origin still remains unsolved.Zasevki malignomov v kosti so znatno pogostejši od primarnih novotvorb. Približno 2 % zasevkov, kljub številnim opravljenim preiskavam, ostane brez jasnega mesta izvora. Predstavljeni 59-letni bolnik je bil sprejet zaradi patološkega preloma telesa vretenca L1. Po odstranitvi večine telesa, natančni patološki preiskavi in razširjeni diagnostiki, vprašanje glede izvora primarnega tumorja še vedno ostaja nerazrešeno. ; slv - slovensk

    Case report of a patient with a metastasis in the L1 vertebral body of unknown origin

    Get PDF
    Zasevki malignomov v kosti so znatno pogostejši od primarnih novotvorb. Približno 2 % zasevkov, kljub številnim opravljenim preiskavam, ostane brez jasnega mesta izvora. Predstavljeni 59-letni bolnik je bil sprejet zaradi patološkega preloma telesa vretenca L1. Po odstranitvi večine telesa, natančni patološki preiskavi in razširjeni diagnostiki, vprašanje glede izvora primarnega tumorja še vedno ostaja nerazrešeno.Metastases of bone malignancies are much more common than primary neoplasms. The site of origin remains unknown in approximately 2% of metastases. We present a case of a 59-year-old patient referred to our Institute for pathological fracture of the L1 vertebral body. After removing the majority of the body, a detailed pathological examination and extensive diagnosis, the question of primary tumour origin still remains unsolved

    Gastric antral vascular ectasia (GAVE) - case report

    No full text
    Izhodišča. Žilne ektazije antruma želodca (GAVE) ali lubenični želodec (watermelon stomach) so redek, a pomemben vzrok kronične krvavitve iz prebavne cevi in posledične slabokrvnosti. Bolezen ima svojo značilno endoskopsko in histološko sliko. Patogeneza bolezni je nepojasnjena. Cilj zdravljenja je zmanjšati kronično krvavitev do te mere, da transfuzije niso več potrebne. V literaturi so opisani poskusi zdravljenja z zdravili, endoskopskimi terapevtskimi metodami in z operacijo. Danes se pri zdravljenju GAVE najpogosteje uporablja elektrokoagulacija z argonskim plazemskim koagulatorjem in z laserjem Nd: YAG. Bolniki in metode. Prikazan je primer 77-letne bolnice z žilnimi ektazijami antruma želodca. Bolnica je bila zaradi nepojasnjenega vzroka krvavitve iz prebavne cevi in ponavljajoče se slabokrvnosti kljub nadomeščanju železa odvisna od transfuzij. Uspešno je bila zdravljena z argonsko plazemsko koagulacijo (APC). Dve leti po zdravljenju bolnica ni slabokrvna in ne potrebuje transfuzij. Zaključki. Žilne ektazije antruma želodca so pogosto nespoznane in napačno opredeljene kot erozivni gastritis. Čeprav je bolezen redka, je pomemben vzrok prikrite krvavitve iz zgornje prebavne cevi, zlasti pri starejših ženskah.Background. Gastric antral vascular ectasia (GAVE), or "watermelon stomach" is a rare but important cause of gastrointestinal blood loss and anaemia, and has characteristic endoscopic and histological features. The pathogenesis of this condition remains unclear. The goal in treating a patient with gastric antral vascular ectasia should be the complete elimination of transfusion requirements. Various medical, surgical and endoscopic therapeutic modalities have been attempted with variable success. Currently available evidence favours endoscopic therapy using argon plasma coagulation or Nd: YAG laser. Patients and methods. A case of 77-year-old women with gastric antral vascular ectasia is presented who was transfusion dependent due to recurrent anaemia despite iron supplements. She was successfully treated with argon plasma coagulation (APC). Two years after treatment she didn\u27t have anaemia and no need for transfusion. Conclusions. It is widely belived that GAVE is under-recognized and is most often misinterpreted as antral gastritis. Although rare, it is an important cause of occult upper gastrointestinal bleeding, particularly in elderly women

    Thyrotoxic struma ovarii after thyroid ablation: a case report of laparoscopic management

    Get PDF
    Struma ovarii is a rare type of germ cell tumor and a rare cause of ectopic thyroidal hormonal production. We report a case of laparsocopic management of a thyrotoxic struma ovarii. In a 49-year-old patient, previously treated by ablative surgery and radioactive iodine for Graves\u27 disease, a new onset of hyperthyroidism occurred unexpectedly. A whole-body scan with 131I detected increased pelvic uptake, suggesting struma ovarii. The patient was subsequently treated with laparoscopic bilateral salpingo-oophorectomy. The postoperative course was uneventful. Histopathologic examination revealed the presence of a benign struma ovarii. Three years after treatment the patient is disease free and is receiving thyroid replacement therapy with levothyroxine. In this case the thyrotoxic struma ovarii was diagnosed preoperatively and laparoscopic surgery proved to be a useful and reliable method for ovarian ablation.Struma jajčnika je redka oblika tumorja zarodnih celic, ki predstavlja redek vzrok ektopičnega izločanja ščitničnih hormonov. Poročamo o primeru laparoskopskega zdravljenja strume jajčnika. Pri 49-letni bolnici, ki je bila zaradi Gravesove bolezni predhodno zdravljena z ablativno operacijo in radioaktivnim jodom, se je nepričakovano pojavil hipertiroidizem. Scintigrafija telesa z 131J je pokazala povečano aktivnost v medenici in s tem nakazavala na strumo jajčnika. Bolnico smo zdravili z laparoskopsko običajno adneksektomijo. V pooperativnem poteku ni bilo posebnosti. Histopatološka preiskava je pokazala prisotnost benigne strume jajčnika. Trenutno je bolnica brez znakov bolezni in prejema ščitnično nadomestno zdravljenje z levotiroksinom. V obravnavanem primeru amo še pred operacijo ugotovili diagnozo tirotoksične strume jajčnika, laparoskopska operacija pa se je izkazala za koristno in zanesljivo metodo za odstranitev jajčnika

    Borelijski limfocitom areole pri devetletnem dečku: prikaz primera

    Get PDF

    Phlegmonöse Gastritis bei einer Patientin mit rheumatoider Arthritis

    No full text

    Single nucleotide polymorphisms in genes MACC1, RAD18, MMP7 and SDF-1[alpha] as prognostic factors in resectable colorectal cancer

    Get PDF
    Background: Colorectal cancer (CRC) represents one of the most common malignancies worldwide. Research has indicated that functional gene changes such as single nucleotide polymorphism (SNP) influence carcinogenesis and metastasis and might have an influence on disease relapse. The aim of our study was to evaluate the role of SNPs in selected genes as prognostic markers in resectable CRC. Patients and methods: In total, 163 consecutive patients treated surgically for CRC of stages I, II and III at the University Medical Centre in Maribor in 2007 and 2008 were investigated. DNA was isolated from formalin-fixed paraffin-embedded CRC tissue from the Department of Pathology and SNPs in genes SDF-1alpha, MMP7, RAD18 and MACC1 were genotyped using polymerase chain reaction followed by high resolution melting curve analysis or restriction fragment length polymorphism. Results: We found worse disease-free survival (DFS) for patients with TT genotype of SNP rs1990172 in gene MACC1 (p = 0.029). Next, we found worse DFS for patients with GG genotype for SNP rs373572 in gene RAD18 (p = 0.020). Higher frequency of genotype GG of MMP7 SNP rs11568818 was found in patients with T3/T4 stage (p = 0.014), N1/N2 stage (p = 0.041) and with lymphovascular invasion (p = 0.018). For MACC1 rs1990172 SNP we found higher frequency of genotype TT in patients with T3/T4 staging (p = 0.024). Higher frequency of genotype GG of RAD18 rs373572 was also found in patients with T1/T2 stage with disease relapse (p = 0.041). Conclusions: Our results indicate the role of SNPs as prognostic factors in resectable CRC

    Giant solitary fibrous tumour of the pleura. Case report and review of the literature

    No full text
    Background. Solitary fibrous tumours of the pleura (SFTP) are rare tumours. They are mostly benign. Only around 12% of them are malignant. In the initial stage they are mostly asymptomatic and by growing they cause chest pain, irritating cough and dyspnoea on account of the pressure created on the surrounding structures. Rare giant tumours have compression symptoms on the mediastinal structures. The condition requires tiered diagnostic radiology. Preoperative biopsy is not successful in most cases. The therapy of choice is radical surgical tumour removal. Malignant or non-radically removed benign solitary fibrous tumours of the pleura additionally require neoadjuvant therapy
    corecore